Biodyne Statistics
Total Valuation
Biodyne has a market cap or net worth of KRW 479.50 billion. The enterprise value is 459.12 billion.
Market Cap | 479.50B |
Enterprise Value | 459.12B |
Important Dates
The next estimated earnings date is Wednesday, March 19, 2025.
Earnings Date | Mar 19, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Biodyne has 29.76 million shares outstanding. The number of shares has decreased by -38.82% in one year.
Current Share Class | n/a |
Shares Outstanding | 29.76M |
Shares Change (YoY) | -38.82% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 46.56% |
Owned by Institutions (%) | 1.14% |
Float | 15.91M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 102.91 |
PB Ratio | 11.11 |
P/TBV Ratio | 12.23 |
P/FCF Ratio | 419.59 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -456.56 |
EV / Sales | 100.45 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 401.75 |
Financial Position
The company has a current ratio of 16.89, with a Debt / Equity ratio of 0.00.
Current Ratio | 16.89 |
Quick Ratio | 16.40 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | 0.00 |
Interest Coverage | -10,658.29 |
Financial Efficiency
Return on equity (ROE) is -2.32% and return on invested capital (ROIC) is -2.69%.
Return on Equity (ROE) | -2.32% |
Return on Assets (ROA) | -2.64% |
Return on Capital (ROIC) | -2.69% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.10 |
Inventory Turnover | 6.38 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.60% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -68.60% |
50-Day Moving Average | 18,626.60 |
200-Day Moving Average | 14,380.45 |
Relative Strength Index (RSI) | 41.98 |
Average Volume (20 Days) | 384,501 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biodyne had revenue of KRW 4.57 billion and -1.01 billion in losses. Loss per share was -34.44.
Revenue | 4.57B |
Gross Profit | 1.65B |
Operating Income | -1.87B |
Pretax Income | -1.24B |
Net Income | -1.01B |
EBITDA | -232.55M |
EBIT | -1.87B |
Loss Per Share | -34.44 |
Balance Sheet
The company has 20.38 billion in cash and 4.21 million in debt, giving a net cash position of 20.38 billion or 684.74 per share.
Cash & Cash Equivalents | 20.38B |
Total Debt | 4.21M |
Net Cash | 20.38B |
Net Cash Per Share | 684.74 |
Equity (Book Value) | 42.75B |
Book Value Per Share | 1,450.37 |
Working Capital | 20.49B |
Cash Flow
In the last 12 months, operating cash flow was 1.61 billion and capital expenditures -468.59 million, giving a free cash flow of 1.14 billion.
Operating Cash Flow | 1.61B |
Capital Expenditures | -468.59M |
Free Cash Flow | 1.14B |
FCF Per Share | 38.40 |
Margins
Gross margin is 36.06%, with operating and profit margins of -40.81% and -22.00%.
Gross Margin | 36.06% |
Operating Margin | -40.81% |
Pretax Margin | -27.18% |
Profit Margin | -22.00% |
EBITDA Margin | -5.09% |
EBIT Margin | -40.81% |
FCF Margin | 25.00% |
Dividends & Yields
Biodyne does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 38.82% |
Shareholder Yield | 38.82% |
Earnings Yield | -0.21% |
FCF Yield | 0.24% |
Stock Splits
The last stock split was on February 28, 2024. It was a forward split with a ratio of 5.
Last Split Date | Feb 28, 2024 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Biodyne has an Altman Z-Score of 166.02.
Altman Z-Score | 166.02 |
Piotroski F-Score | n/a |